-
JAMA Netw Open: The effects of the new weight loss drug Bimagrumab on the quality of body fat in type 2 diabetes and obesity
Time of Update: 2021-01-24
The double-blind, placebo-controlled, 48-week, Phase 2 randomized clinical trial was conducted in adults with type 2 diabetes in nine regions of the United States and the United Kingdom, with a body mass index of between 28 and 40 and levels of hemoglobin glycation (HbA1c) between 6.5 and 10.0 percent.
-
The FDA approves a liquid antioxidant for food contact materials
Time of Update: 2020-10-10
WESTON705 liquid antioxidants from Addivant, Connecticut, have been approved by the U.S. FDA for use in food contact materials, foreign media reported.
The FDA has approved the material for use in food-contact applications, such as food packaging.
-
TJBio and MorphoSys announce that TJ210/MOR210 has been approved by the FDA for clinical trials
Time of Update: 2020-09-30
the terms of the agreement, Tiantian Bio has exclusive rights to develop and commercialize TJ210/MOR210 in Greater China and Korea, while MorphoSys reserves rights in other parts of the world.
, the two companies are also working together on MorphoSys' self-developed human-source CD38 monoclonal antibody TJ202/MOR202.
-
The 2020 edition of the CSCO Guidelines for the Diagnosis and Treatment of Primary Liver Cancer has four bright spots in the first-line treatment pattern
Time of Update: 2020-09-17
based on a single-arm, multi-center Phase 2 clinical trial led by Professor Qin Shuxuan as the lead researcher (PI) for the first-line treatment of liver cancer with Karelli-Zhu single-drug combination chemotherapy.
-
Antibody drug conjugatetro Trodelvy significantly improves PFS: Phase III study reaches end in patients with triple-negative breast cancer
Time of Update: 2020-07-14
Immunomedics announced that its antibody drug, the conjugate Trotecan-hziy, was used in patients with three negative breast cancer (TNBC), who had previously received at least two anti-metastasis
-
Remdesivir becomes first anti-COVID-19 drug recommended by EU
Time of Update: 2020-07-12
The European Medicines Administration 's EMA Human Drug Council (CHMP) supports the use of Gilead's Remdesivir for the treatment of patients with pneumonia with a new coronavirus COVID-19 infecte
-
New anti-AIDS drug Selzentry goes on sale next month
Time of Update: 2020-07-07
Selzentry, a new anti-AIDS drug Pfizer, has been approved by the U.S FDA and will go on sale next month Selzentry is the first new anti-AIDS drug developed since 2003 and works by blocking the main
-
FDA approves Novartis IL-17A monoantiticx for treatment of non-radiation siegenle spinal arthritis
Time of Update: 2020-06-25
The FDA approved Novartis' fourth anti-IL-17A monoantiticcos (secukinumab) for the treatment of adult patients with non-radiation axial spinal arthritis The FDA approved Lilly's Taltz just a few
-
New drugs are on the rise! Small cell lung cancer expected to take off the "Magic King" hat
Time of Update: 2020-06-15
When small cell lung cancer is detected, metastasis is often occurred, the prognosis is poor, the five-year survival rate is less than 10% But in recent years, with the breakthrough of immunotherapy,
-
FDA approves Lilly Alimta (injection pemele) with a new indication
Time of Update: 2020-06-11
recently, the U.S Pharmaceuticals announced that the U.S Food and Drug ( FDA ( ) has approved alimta (injection-based pemephore) combined carboplatin and Mercado-1 immunotherapy Keytruda (Pembr
-
Sanofi dengue vaccine Dengvaxia has been approved by the European Commission
Time of Update: 2020-06-10
dengue fever (Dengue) is an acute insect-borne infection caused by the mosquito-borne transmission of the dengue virus Clinical manifestations of high fever, headache, muscle, bone joint severe sore
-
FDA approves BAVENCIO in association with axiathani as a first-line treatment for patients with advanced renal cell carcinoma (RCC
Time of Update: 2020-06-09
recently, the United States The FDA (http:// approved BAVENCIO (Avelumab) in conjunction with INLYTA as a first-line treatment for patients with advanced renal cell carcinoma (RCC) this is also
-
The State Drug Administration has conditional approval of the application for registration of the import of injections by Thedenosumab
Time of Update: 2020-06-09
recently, the State Drug Administration has conditionally approved the application for registration of the injection of Denosumab, which is not surgically removed or surgically removed for adults an
-
Novartis launches new generation of eye drug Beovu (brolucizumab) in US
Time of Update: 2020-06-07
, Novartis, the swiss pharmaceutical (http:// giant, announced the launch of a new generation of ophthalmic drug (http:// Beovu (http:// in the United States to treat wet age-related macular de
-
FDA accepts listing application for oberic acid treatment for non-alcoholic fatty hepatitis
Time of Update: 2020-06-07
recently, Intercept announced The FDA (http:// has accepted a market ingressation application for the treatment of non-alcoholic fatty hepatitis (NASH) for liver fibrosis and has been qualified f
